• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Glycemic control of type 2 diabetic patients with coronavirus disease during hospitalization: a proposal for early insulin therapy.

作者信息

Nakhleh Afif, Shehadeh Naim

机构信息

Institute of Endocrinology, Diabetes and Metabolism, Rambam Health Care Campus, Haifa, Israel.

出版信息

Am J Physiol Endocrinol Metab. 2020 Jun 1;318(6):E835-E837. doi: 10.1152/ajpendo.00163.2020.

DOI:10.1152/ajpendo.00163.2020
PMID:32401039
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7237499/
Abstract
摘要

相似文献

1
Glycemic control of type 2 diabetic patients with coronavirus disease during hospitalization: a proposal for early insulin therapy.2型糖尿病合并冠状病毒病患者住院期间的血糖控制：早期胰岛素治疗建议
Am J Physiol Endocrinol Metab. 2020 Jun 1;318(6):E835-E837. doi: 10.1152/ajpendo.00163.2020.
2
Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies.治疗 COVID-19 患者的 2 型糖尿病：注射治疗的潜在益处。
Cardiovasc Diabetol. 2020 Jul 22;19(1):115. doi: 10.1186/s12933-020-01090-9.
3
Human recombinant soluble ACE2 in severe COVID-19.严重新型冠状病毒肺炎中的人重组可溶性血管紧张素转换酶2
Lancet Respir Med. 2020 Nov;8(11):1154-1158. doi: 10.1016/S2213-2600(20)30418-5. Epub 2020 Sep 24.
4
Diabetes or endocrinopathy admitted in the COVID-19 ward.因糖尿病或内分泌疾病入住新冠病房。
Eur J Clin Invest. 2020 Jul;50(7):e13262. doi: 10.1111/eci.13262. Epub 2020 May 24.
5
Diabetes care during the acute phase of infection in ICU patients with specific attention to COVID-19 outbreak.重症监护病房（ICU）患者感染急性期的糖尿病护理，尤其关注新型冠状病毒肺炎（COVID-19）疫情。
Anaesth Crit Care Pain Med. 2020 Jun;39(3):375-379. doi: 10.1016/j.accpm.2020.06.004. Epub 2020 Jun 17.
6
Successful blood glucose management of a severe COVID-19 patient with diabetes: A case report.一名患有糖尿病的重症 COVID-19 患者的成功血糖管理：病例报告。
Medicine (Baltimore). 2020 Jun 26;99(26):e20844. doi: 10.1097/MD.0000000000020844.
7
Kidney diseases in the time of COVID-19: major challenges to patient care.新冠疫情时期的肾脏疾病：患者护理面临的重大挑战
J Clin Invest. 2020 Jun 1;130(6):2749-2751. doi: 10.1172/JCI138871.
8
Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline.医院连续血糖监测与自动胰岛素给药系统共识指南
J Diabetes Sci Technol. 2020 Nov;14(6):1035-1064. doi: 10.1177/1932296820954163. Epub 2020 Sep 28.
9
COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.2019冠状病毒病：糖尿病与心血管疾病管理的考量
J Diabetes Sci Technol. 2020 Jul;14(4):723-724. doi: 10.1177/1932296820930025. Epub 2020 May 30.
10
Does glycemic control rescue type 2 diabetes patients from COVID-19-related deaths?血糖控制能否使 2 型糖尿病患者免于 COVID-19 相关死亡？
J Diabetes Investig. 2020 Jul;11(4):792-794. doi: 10.1111/jdi.13320. Epub 2020 Jul 10.

引用本文的文献

1
Pediatric diabetic ketoacidosis as type 1 diabetes debut with concurrent SARS-CoV-2 infection: A case report.1型糖尿病初发伴新型冠状病毒2型（SARS-CoV-2）感染的小儿糖尿病酮症酸中毒：一例报告
SAGE Open Med Case Rep. 2022 May 13;10:2050313X221097263. doi: 10.1177/2050313X221097263. eCollection 2022.
2
Commentary: A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19. A Metabolic Endocrinology Perspective.评论：血糖水平在新冠病毒疾病严重程度中作用的机器生成观点。代谢内分泌学视角。
Front Endocrinol (Lausanne). 2022 Apr 28;13:877973. doi: 10.3389/fendo.2022.877973. eCollection 2022.
3
Diabetic Ketoacidosis in Patients With COVID-19.新冠肺炎患者的糖尿病酮症酸中毒
Am J Med Sci. 2021 May;361(5):668-669. doi: 10.1016/j.amjms.2020.11.027. Epub 2020 Nov 25.
4
Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion.在 COVID-19 期间关注心脏代谢，在资源有限的情况下节约资源：基于临床实践的专家意见。
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):55-62. doi: 10.1016/j.dsx.2020.11.014. Epub 2020 Nov 20.
5
Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle.肥胖、糖尿病与 COVID-19：一种从东方蔓延而来的传染病，撞上了不健康的西方生活方式所带来的后果。
Front Endocrinol (Lausanne). 2020 Sep 17;11:582870. doi: 10.3389/fendo.2020.582870. eCollection 2020.
6
Lifestyle and severe SARS-CoV-2 infections: Does the individual metabolic burden determines the outcome?生活方式与严重的新冠病毒感染：个体的代谢负担会决定结果吗？
J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320963929. doi: 10.1177/1470320320963929.
7
Potential pathophysiological mechanisms leading to increased COVID-19 susceptibility and severity in obesity.导致肥胖人群对COVID-19易感性增加和病情加重的潜在病理生理机制。
Obes Med. 2020 Sep;19:100259. doi: 10.1016/j.obmed.2020.100259. Epub 2020 May 26.

本文引用的文献

1
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.使用 ISARIC WHO 临床特征协议住院的 20133 例英国新冠患者的特征：前瞻性观察队列研究。
BMJ. 2020 May 22;369:m1985. doi: 10.1136/bmj.m1985.
2
Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus.一名新诊断为糖尿病的患者因新冠病毒感染诱发糖尿病酮症酸中毒。
Diabetes Res Clin Pract. 2020 Jun;164:108166. doi: 10.1016/j.diabres.2020.108166. Epub 2020 Apr 24.
3
Practical recommendations for the management of diabetes in patients with COVID-19.关于 COVID-19 患者糖尿病管理的实用建议。
Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-550. doi: 10.1016/S2213-8587(20)30152-2. Epub 2020 Apr 23.
4
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.使用临床级别的可溶性人血管紧张素转化酶 2 抑制工程化人类组织中的 SARS-CoV-2 感染。
Cell. 2020 May 14;181(4):905-913.e7. doi: 10.1016/j.cell.2020.04.004. Epub 2020 Apr 24.
5
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2.利用人血管紧张素转化酶 2 进入 SARS-CoV-2 的结构和功能基础
Cell. 2020 May 14;181(4):894-904.e9. doi: 10.1016/j.cell.2020.03.045. Epub 2020 Apr 9.
6
Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China.中国新冠肺炎死亡患者的临床特征。
JAMA Netw Open. 2020 Apr 1;3(4):e205619. doi: 10.1001/jamanetworkopen.2020.5619.
7
COVID-19: immunopathology and its implications for therapy.新型冠状病毒肺炎：免疫病理学及其治疗意义。
Nat Rev Immunol. 2020 May;20(5):269-270. doi: 10.1038/s41577-020-0308-3.
8
Diabetes is a risk factor for the progression and prognosis of COVID-19.糖尿病是新冠病毒疾病（COVID-19）进展和预后的一个风险因素。
Diabetes Metab Res Rev. 2020 Oct;36(7):e3319. doi: 10.1002/dmrr.3319. Epub 2020 Apr 7.
9
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
10
15. Diabetes Care in the Hospital: .15. 医院中的糖尿病护理：。
Diabetes Care. 2020 Jan;43(Suppl 1):S193-S202. doi: 10.2337/dc20-S015.